155 related articles for article (PubMed ID: 32298379)
21. Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status.
Doroudchi M; Saidi M; Malekzadeh M; Golmoghaddam H; Khezri A; Ghaderi A
Future Oncol; 2013 Feb; 9(2):295-304. PubMed ID: 23414478
[TBL] [Abstract][Full Text] [Related]
22. Impaired Homocysteine Metabolism Associated with High Plasma Interleukin-17A Levels, a Pro-Atherogenic Marker, in an Endogamous Population of North India.
Kaur L; Garg PR; Ghosh PK; Saraswathy KN
Ethn Dis; 2018; 28(4):525-530. PubMed ID: 30405296
[TBL] [Abstract][Full Text] [Related]
23. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
Njei B; McCarty TR; Birk JW
J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
[TBL] [Abstract][Full Text] [Related]
24. The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.
Lindenmann J; Fink-Neuboeck N; Koesslbacher M; Pichler M; Stojakovic T; Roller RE; Maier A; Anegg U; Smolle J; Smolle-Juettner FM
J Surg Oncol; 2014 Nov; 110(6):645-50. PubMed ID: 24975677
[TBL] [Abstract][Full Text] [Related]
25. Influence of treatment modality in outcomes for different stages of resectable esophageal adenocarcinomas.
Allan BJ; Pedroso F; Gennis ER; Livingstone AS; Montero A; Lally B; Ardalan B; Koniaris LG; Solomon NL; Franceschi D
Ann Surg Oncol; 2013 May; 20(5):1660-7. PubMed ID: 23456314
[TBL] [Abstract][Full Text] [Related]
26. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
28. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma.
Steins A; Ebbing EA; Creemers A; van der Zalm AP; Jibodh RA; Waasdorp C; Meijer SL; van Delden OM; Krishnadath KK; Hulshof MCCM; Bennink RJ; Punt CJA; Medema JP; Bijlsma MF; van Laarhoven HWM
Int J Cancer; 2019 Nov; 145(10):2792-2803. PubMed ID: 31018252
[TBL] [Abstract][Full Text] [Related]
29. Stage selection for neoadjuvant radiotherapy in non-cervical esophageal cancer: A propensity score-matched study based on the SEER database.
Ma K; Yang Y; Wang S; Yang X; Lu T; Xi J; Jiang W; Zhan C; Zhu Y; Wang Q
Thorac Cancer; 2018 Sep; 9(9):1111-1120. PubMed ID: 29961955
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
Yoneda M; Fujiwara H; Furutani A; Ikai A; Tada H; Shiozaki A; Komatsu S; Kubota T; Ichikawa D; Okamoto K; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Otsuji E
Anticancer Res; 2013 Jun; 33(6):2699-705. PubMed ID: 23749929
[TBL] [Abstract][Full Text] [Related]
31. D-mannose: a novel prognostic biomarker for patients with esophageal adenocarcinoma.
Gu J; Liang D; Pierzynski JA; Zheng L; Ye Y; Zhang J; Ajani JA; Wu X
Carcinogenesis; 2017 Feb; 38(2):162-167. PubMed ID: 28062409
[TBL] [Abstract][Full Text] [Related]
32. IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients.
de Oliveira PS; Cardoso PR; Lima EV; Pereira MC; Duarte AL; Pitta Ida R; Rêgo MJ; Pitta MG
Mediators Inflamm; 2015; 2015():819149. PubMed ID: 26351408
[TBL] [Abstract][Full Text] [Related]
33. Circulatory Tumor Cells in Esophageal Adenocarcinoma.
Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():177-186. PubMed ID: 29600370
[TBL] [Abstract][Full Text] [Related]
34. Influence of autologous and homologous blood transfusion on interleukins and tumor necrosis factor-α in peri-operative patients with esophageal cancer.
Xing YL; Wang YC
Asian Pac J Cancer Prev; 2014; 15(18):7831-4. PubMed ID: 25292072
[TBL] [Abstract][Full Text] [Related]
35. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
[TBL] [Abstract][Full Text] [Related]
36. The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients.
Lemancewicz D; Bolkun L; Jablonska E; Czeczuga-Semeniuk E; Kostur A; Kloczko J; Dzieciol J
Med Sci Monit; 2012 Jan; 18(1):BR54-59. PubMed ID: 22207110
[TBL] [Abstract][Full Text] [Related]
37. Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease.
Green HF; Khosousi S; Svenningsson P
J Parkinsons Dis; 2019; 9(4):705-709. PubMed ID: 31524180
[TBL] [Abstract][Full Text] [Related]
38. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
39. Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.
Li W; Li N; Wang R; Li Q; Wu H
Hepatol Int; 2015 Apr; 9(2):218-23. PubMed ID: 25794550
[TBL] [Abstract][Full Text] [Related]
40. Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.
Meaney CL; Zingone A; Brown D; Yu Y; Cao L; Ryan BM
Oncotarget; 2017 Jun; 8(25):40946-40957. PubMed ID: 28402963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
